Changing the metabolic environment of a tumor could affect much more than its ATP supply. In our proposed Therapeutic Hypoglycemia approach, the aim is to reduce glucose and glutamine availability while increasing ketones and modifying buffering. The interesting question is how these changes interact across different cell types.
In glycolytic tumor regions, lactate production and acid handling contribute to an acidic, immunosuppressive tumor environment. Local lactate concentration and pH also depend on transport, buffering and clearance.
Tumor-infiltrating T cells must fight cancer in an environment where glucose is often scarce. An important question is whether ketones can sustain their ability to kill cancer cells when glucose availability is severely restricted.